Gaeta Renee
SEC insider (Form 3/4/5 filer). CIK 0001742428. Chief Financial Officer at Outset Medical, Inc. (OM) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in SAN JOSE, CA.
Companies Gaeta Renee has filed insider reports for
- Outset Medical, Inc. (OM): Officer, Chief Financial Officer
- Candel Therapeutics, Inc. (CADL): Director
Gaeta Renee
CIK: 0001742428
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 17, 2026OM
Outset Medical, Inc.
SaleDirect4.5K shares at avg. $4.39$20K - Jun 26, 2026OM
Outset Medical, Inc.
AwardDirect71.6K shares- - Jun 23, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32K shares- - Jun 3, 2026OM
Outset Medical, Inc.
SaleDirect17.7K shares at avg. $4.94$87K - Jun 17, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
14.2K shares- - Jun 10, 2025OM
Outset Medical, Inc.
AwardDirect131.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 |  OM Outset Medical, Inc. | Sale | 4,543 | $4.39 | $19,944 | Direct |
| Jun 26, 2026 | OM Outset Medical, Inc. | Award | 71,630 | - | $0 | Direct |
| Jun 23, 2026 |  CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| Jun 3, 2026 | OM Outset Medical, Inc. | Sale | 17,672 | $4.94 | $87,300 | Direct |
| Jun 17, 2025 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 14,240 | - | - | Direct |
| Jun 10, 2025 | OM Outset Medical, Inc. | Award | 131,425 | - | - | Direct |
1-6 of 6 transactions